These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 26513421)

  • 1. Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake.
    Mirshafiee V; Kim R; Park S; Mahmoudi M; Kraft ML
    Biomaterials; 2016 Jan; 75():295-304. PubMed ID: 26513421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum.
    Mirshafiee V; Kim R; Mahmoudi M; Kraft ML
    Int J Biochem Cell Biol; 2016 Jun; 75():188-95. PubMed ID: 26643610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stealth effect of biomolecular corona on nanoparticle uptake by immune cells.
    Caracciolo G; Palchetti S; Colapicchioni V; Digiacomo L; Pozzi D; Capriotti AL; La Barbera G; Laganà A
    Langmuir; 2015 Oct; 31(39):10764-73. PubMed ID: 26378619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional dissection of the plasma corona of SiO₂-NPs spots histidine rich glycoprotein as a major player able to hamper nanoparticle capture by macrophages.
    Fedeli C; Segat D; Tavano R; Bubacco L; De Franceschi G; de Laureto PP; Lubian E; Selvestrel F; Mancin F; Papini E
    Nanoscale; 2015 Nov; 7(42):17710-28. PubMed ID: 26451907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
    Shang L; Nienhaus GU
    Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic and biological identities of polymeric nanoparticles influencing the cellular delivery: An immunological link.
    Rezaei G; Daghighi SM; Raoufi M; Esfandyari-Manesh M; Rahimifard M; Mobarakeh VI; Kamalzare S; Ghahremani MH; Atyabi F; Abdollahi M; Rezaee F; Dinarvand R
    J Colloid Interface Sci; 2019 Nov; 556():476-491. PubMed ID: 31473538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of silica nanoparticle surface chemistry on protein corona formation and consequential interactions with biological cells.
    Kurtz-Chalot A; Villiers C; Pourchez J; Boudard D; Martini M; Marche PN; Cottier M; Forest V
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():16-24. PubMed ID: 28415450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Protein Corona on Active and Passive Targeting of Cyclic RGD Peptide-Functionalized PEGylation Nanoparticles.
    Su G; Jiang H; Xu B; Yu Y; Chen X
    Mol Pharm; 2018 Nov; 15(11):5019-5030. PubMed ID: 30222356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of the protein corona using tunable resistive pulse sensing: determining the change and distribution of a particle's surface charge.
    Blundell ELCJ; Healey MJ; Holton E; Sivakumaran M; Manstana S; Platt M
    Anal Bioanal Chem; 2016 Aug; 408(21):5757-5768. PubMed ID: 27287012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells.
    Pozzi D; Colapicchioni V; Caracciolo G; Piovesana S; Capriotti AL; Palchetti S; De Grossi S; Riccioli A; Amenitsch H; Laganà A
    Nanoscale; 2014 Mar; 6(5):2782-92. PubMed ID: 24463404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of nanoparticle surface functionalization on the protein corona and cellular adhesion, uptake and transport.
    Abdelkhaliq A; van der Zande M; Punt A; Helsdingen R; Boeren S; Vervoort JJM; Rietjens IMCM; Bouwmeester H
    J Nanobiotechnology; 2018 Sep; 16(1):70. PubMed ID: 30219059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatory interpretation of protein corona and shear stress for active cancer targeting of bioorthogonally clickable gelatin-oleic nanoparticles.
    Meghani NM; Amin H; Park C; Cui JH; Cao QR; Choi KH; Lee BJ
    Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110760. PubMed ID: 32279783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Macrophage Recognition through the Interplay of Nanoparticle Surface Functionality and Protein Corona.
    Saha K; Rahimi M; Yazdani M; Kim ST; Moyano DF; Hou S; Das R; Mout R; Rezaee F; Mahmoudi M; Rotello VM
    ACS Nano; 2016 Apr; 10(4):4421-30. PubMed ID: 27040442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum heat inactivation affects protein corona composition and nanoparticle uptake.
    Lesniak A; Campbell A; Monopoli MP; Lynch I; Salvati A; Dawson KA
    Biomaterials; 2010 Dec; 31(36):9511-8. PubMed ID: 21059466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bypassing Protein Corona Issue on Active Targeting: Zwitterionic Coatings Dictate Specific Interactions of Targeting Moieties and Cell Receptors.
    Safavi-Sohi R; Maghari S; Raoufi M; Jalali SA; Hajipour MJ; Ghassempour A; Mahmoudi M
    ACS Appl Mater Interfaces; 2016 Sep; 8(35):22808-18. PubMed ID: 27526263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein Corona Influences Cellular Uptake of Gold Nanoparticles by Phagocytic and Nonphagocytic Cells in a Size-Dependent Manner.
    Cheng X; Tian X; Wu A; Li J; Tian J; Chong Y; Chai Z; Zhao Y; Chen C; Ge C
    ACS Appl Mater Interfaces; 2015 Sep; 7(37):20568-75. PubMed ID: 26364560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ low-immunogenic albumin-conjugating-corona guiding nanoparticles for tumor-targeting chemotherapy.
    Li Z; Li D; Li Q; Luo C; Li J; Kou L; Zhang D; Zhang H; Zhao S; Kan Q; Liu J; Zhang P; Liu X; Sun Y; Wang Y; He Z; Sun J
    Biomater Sci; 2018 Sep; 6(10):2681-2693. PubMed ID: 30151516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties.
    Obst K; Yealland G; Balzus B; Miceli E; Dimde M; Weise C; Eravci M; Bodmeier R; Haag R; Calderón M; Charbaji N; Hedtrich S
    Biomacromolecules; 2017 Jun; 18(6):1762-1771. PubMed ID: 28511014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery.
    Barrán-Berdón AL; Pozzi D; Caracciolo G; Capriotti AL; Caruso G; Cavaliere C; Riccioli A; Palchetti S; Laganà A
    Langmuir; 2013 May; 29(21):6485-94. PubMed ID: 23631648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protein corona and its effects on nanoparticle-based drug delivery systems.
    Li H; Wang Y; Tang Q; Yin D; Tang C; He E; Zou L; Peng Q
    Acta Biomater; 2021 Jul; 129():57-72. PubMed ID: 34048973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.